Rank | Gene Set | Z-score |
---|---|---|
1 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 9.94330383 |
2 | * protoporphyrinogen IX metabolic process (GO:0046501) | 9.83547098 |
3 | oxygen transport (GO:0015671) | 8.95550493 |
4 | gas transport (GO:0015669) | 8.14095947 |
5 | erythrocyte development (GO:0048821) | 7.60686301 |
6 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 6.88383968 |
7 | * heme biosynthetic process (GO:0006783) | 6.42908603 |
8 | L-phenylalanine catabolic process (GO:0006559) | 6.33906811 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.33906811 |
10 | * tetrapyrrole biosynthetic process (GO:0033014) | 6.19846725 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.10102634 |
12 | L-phenylalanine metabolic process (GO:0006558) | 6.10102634 |
13 | iron ion import (GO:0097286) | 6.07838271 |
14 | * porphyrin-containing compound metabolic process (GO:0006778) | 6.05099202 |
15 | myeloid cell development (GO:0061515) | 5.82995575 |
16 | * heme metabolic process (GO:0042168) | 5.70980950 |
17 | cysteine metabolic process (GO:0006534) | 5.64825042 |
18 | lysine metabolic process (GO:0006553) | 5.56367791 |
19 | lysine catabolic process (GO:0006554) | 5.56367791 |
20 | aromatic amino acid family catabolic process (GO:0009074) | 5.47565867 |
21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.11273294 |
22 | hemoglobin metabolic process (GO:0020027) | 5.07352176 |
23 | glyoxylate metabolic process (GO:0046487) | 5.06437380 |
24 | hepatocyte apoptotic process (GO:0097284) | 4.98032017 |
25 | regulation of response to osmotic stress (GO:0047484) | 4.82453430 |
26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.80677871 |
27 | kynurenine metabolic process (GO:0070189) | 4.79940809 |
28 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.77892737 |
29 | indole-containing compound catabolic process (GO:0042436) | 4.72971983 |
30 | indolalkylamine catabolic process (GO:0046218) | 4.72971983 |
31 | tryptophan catabolic process (GO:0006569) | 4.72971983 |
32 | bile acid biosynthetic process (GO:0006699) | 4.59128021 |
33 | negative regulation of fibrinolysis (GO:0051918) | 4.54634681 |
34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.47962804 |
35 | tryptophan metabolic process (GO:0006568) | 4.47237567 |
36 | heme transport (GO:0015886) | 4.46064537 |
37 | megakaryocyte development (GO:0035855) | 4.42120320 |
38 | sulfur amino acid catabolic process (GO:0000098) | 4.40466300 |
39 | definitive hemopoiesis (GO:0060216) | 4.37050801 |
40 | positive regulation of granulocyte differentiation (GO:0030854) | 4.32839679 |
41 | protein carboxylation (GO:0018214) | 4.31659401 |
42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.31659401 |
43 | amino-acid betaine metabolic process (GO:0006577) | 4.30385314 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 4.30007277 |
45 | high-density lipoprotein particle remodeling (GO:0034375) | 4.29355260 |
46 | regulation of fibrinolysis (GO:0051917) | 4.27774846 |
47 | aspartate family amino acid catabolic process (GO:0009068) | 4.23460190 |
48 | regulation of protein activation cascade (GO:2000257) | 4.22432728 |
49 | complement activation, alternative pathway (GO:0006957) | 4.15252786 |
50 | urea metabolic process (GO:0019627) | 4.13980724 |
51 | urea cycle (GO:0000050) | 4.13980724 |
52 | * tetrapyrrole metabolic process (GO:0033013) | 4.10466376 |
53 | homocysteine metabolic process (GO:0050667) | 4.09424062 |
54 | cellular ketone body metabolic process (GO:0046950) | 4.08180740 |
55 | serine family amino acid catabolic process (GO:0009071) | 4.05429121 |
56 | erythrocyte maturation (GO:0043249) | 4.00077342 |
57 | plasma lipoprotein particle clearance (GO:0034381) | 3.98185434 |
58 | cofactor catabolic process (GO:0051187) | 3.96380265 |
59 | regulation of complement activation (GO:0030449) | 3.95876341 |
60 | alpha-amino acid catabolic process (GO:1901606) | 3.93752998 |
61 | regulation of RNA export from nucleus (GO:0046831) | 3.93125589 |
62 | ethanol oxidation (GO:0006069) | 3.92668507 |
63 | nitrogen cycle metabolic process (GO:0071941) | 3.91638606 |
64 | short-chain fatty acid metabolic process (GO:0046459) | 3.88012521 |
65 | aromatic amino acid family metabolic process (GO:0009072) | 3.86996353 |
66 | bile acid metabolic process (GO:0008206) | 3.86931524 |
67 | reverse cholesterol transport (GO:0043691) | 3.85642767 |
68 | serine family amino acid metabolic process (GO:0009069) | 3.85134738 |
69 | glutamate metabolic process (GO:0006536) | 3.82906358 |
70 | acylglycerol homeostasis (GO:0055090) | 3.74924340 |
71 | triglyceride homeostasis (GO:0070328) | 3.74924340 |
72 | acetyl-CoA metabolic process (GO:0006084) | 3.74208156 |
73 | plasma lipoprotein particle remodeling (GO:0034369) | 3.70608922 |
74 | protein-lipid complex remodeling (GO:0034368) | 3.70608922 |
75 | macromolecular complex remodeling (GO:0034367) | 3.70608922 |
76 | fatty acid beta-oxidation (GO:0006635) | 3.70388504 |
77 | cellular amino acid catabolic process (GO:0009063) | 3.67991041 |
78 | fatty acid oxidation (GO:0019395) | 3.67362859 |
79 | carnitine metabolic process (GO:0009437) | 3.66027865 |
80 | regulation of erythrocyte differentiation (GO:0045646) | 3.65905874 |
81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.65559192 |
82 | phospholipid efflux (GO:0033700) | 3.64304969 |
83 | glycine metabolic process (GO:0006544) | 3.63329408 |
84 | tyrosine metabolic process (GO:0006570) | 3.62198326 |
85 | nuclear pore complex assembly (GO:0051292) | 3.62050757 |
86 | lipid oxidation (GO:0034440) | 3.59664306 |
87 | regulation of cholesterol esterification (GO:0010872) | 3.59460821 |
88 | cholesterol efflux (GO:0033344) | 3.57641975 |
89 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.54038922 |
90 | response to mercury ion (GO:0046689) | 3.53749429 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 3.50921611 |
92 | ketone body metabolic process (GO:1902224) | 3.50411086 |
93 | drug transmembrane transport (GO:0006855) | 3.50329608 |
94 | embryonic hemopoiesis (GO:0035162) | 3.49269159 |
95 | coenzyme catabolic process (GO:0009109) | 3.48139438 |
96 | cellular modified amino acid catabolic process (GO:0042219) | 3.47505936 |
97 | granulocyte differentiation (GO:0030851) | 3.47283610 |
98 | blood coagulation, intrinsic pathway (GO:0007597) | 3.45962933 |
99 | N-terminal protein amino acid acetylation (GO:0006474) | 3.44988826 |
100 | fatty acid catabolic process (GO:0009062) | 3.44879023 |
101 | negative regulation of cholesterol transport (GO:0032375) | 3.40789978 |
102 | negative regulation of sterol transport (GO:0032372) | 3.40789978 |
103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.40028328 |
104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.40028328 |
105 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.38321224 |
106 | organic acid catabolic process (GO:0016054) | 3.37217472 |
107 | carboxylic acid catabolic process (GO:0046395) | 3.37217472 |
108 | * plasma lipoprotein particle assembly (GO:0034377) | 3.36959687 |
109 | valine metabolic process (GO:0006573) | 3.36822515 |
110 | monocarboxylic acid catabolic process (GO:0072329) | 3.36039610 |
111 | response to nitrosative stress (GO:0051409) | 3.35537801 |
112 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.35144427 |
113 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.34504621 |
114 | arginine metabolic process (GO:0006525) | 3.32274452 |
115 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.32230261 |
116 | positive regulation of lipid catabolic process (GO:0050996) | 3.31876394 |
117 | cellular biogenic amine catabolic process (GO:0042402) | 3.26470971 |
118 | amine catabolic process (GO:0009310) | 3.26470971 |
119 | benzene-containing compound metabolic process (GO:0042537) | 3.24418547 |
120 | indolalkylamine metabolic process (GO:0006586) | 3.24047187 |
121 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.22548807 |
122 | positive regulation of receptor recycling (GO:0001921) | 3.21199300 |
123 | positive regulation of response to oxidative stress (GO:1902884) | 3.20451914 |
124 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.20451914 |
125 | microglial cell activation (GO:0001774) | 3.13317675 |
126 | platelet formation (GO:0030220) | 3.11722523 |
127 | regulation of platelet aggregation (GO:0090330) | 3.07197587 |
128 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.05927513 |
129 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.05927513 |
130 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.05655902 |
131 | * erythrocyte differentiation (GO:0030218) | 3.03193857 |
132 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.02999343 |
133 | cellular response to arsenic-containing substance (GO:0071243) | 2.99071266 |
134 | regulation of oxidative phosphorylation (GO:0002082) | 2.97501112 |
135 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.96465772 |
136 | * pigment biosynthetic process (GO:0046148) | 2.95481103 |
137 | nuclear pore organization (GO:0006999) | 2.95333834 |
138 | mitochondrion degradation (GO:0000422) | 2.94328124 |
139 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.91496442 |
140 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.90906400 |
141 | protein K11-linked deubiquitination (GO:0035871) | 2.89435405 |
142 | glycine transport (GO:0015816) | 2.88257137 |
143 | negative regulation of histone acetylation (GO:0035067) | 2.86194158 |
144 | histone mRNA catabolic process (GO:0071044) | 2.84073637 |
145 | pore complex assembly (GO:0046931) | 2.80375267 |
146 | one-carbon compound transport (GO:0019755) | 2.79065816 |
147 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.75854960 |
148 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.71970913 |
149 | * pigment metabolic process (GO:0042440) | 2.69979059 |
150 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.69702369 |
151 | dopamine transport (GO:0015872) | 2.69101637 |
152 | dosage compensation (GO:0007549) | 2.68304479 |
153 | positive regulation of B cell differentiation (GO:0045579) | 2.64189278 |
154 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.63864004 |
155 | regulation of granulocyte differentiation (GO:0030852) | 2.63035489 |
156 | response to iron ion (GO:0010039) | 2.62365248 |
157 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.59758569 |
158 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.58700207 |
159 | hemopoiesis (GO:0030097) | 2.56665025 |
160 | actin filament capping (GO:0051693) | 2.54433339 |
161 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.53440133 |
162 | pentose-phosphate shunt (GO:0006098) | 2.53029802 |
163 | * response to arsenic-containing substance (GO:0046685) | 2.52774258 |
164 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52635023 |
165 | histone H3-K36 demethylation (GO:0070544) | 2.51760044 |
166 | regulation of receptor recycling (GO:0001919) | 2.50715968 |
167 | DNA topological change (GO:0006265) | 2.49641877 |
168 | negative regulation of protein acetylation (GO:1901984) | 2.47489713 |
169 | cellular response to virus (GO:0098586) | 2.47105722 |
170 | response to thyroid hormone (GO:0097066) | 2.46429837 |
171 | ovulation from ovarian follicle (GO:0001542) | 2.44487640 |
172 | neutrophil activation involved in immune response (GO:0002283) | 2.44128926 |
173 | negative regulation of necroptotic process (GO:0060546) | 2.43416452 |
174 | neutrophil mediated immunity (GO:0002446) | 2.41013346 |
175 | hydrogen peroxide catabolic process (GO:0042744) | 2.40758772 |
176 | regulation of necroptotic process (GO:0060544) | 2.40383801 |
177 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.40075529 |
178 | protein export from nucleus (GO:0006611) | 2.39987546 |
179 | NADPH regeneration (GO:0006740) | 2.37567868 |
180 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.36508626 |
181 | regulation of response to reactive oxygen species (GO:1901031) | 2.36498902 |
182 | myeloid leukocyte mediated immunity (GO:0002444) | 2.35898188 |
183 | cellular hyperosmotic response (GO:0071474) | 2.34083424 |
184 | protein K48-linked deubiquitination (GO:0071108) | 2.33840822 |
185 | modulation by virus of host process (GO:0019054) | 2.33830804 |
186 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.32070869 |
187 | regulation of beta-amyloid formation (GO:1902003) | 2.31872318 |
188 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.31428167 |
189 | cellular response to gamma radiation (GO:0071480) | 2.30774459 |
190 | cellular response to epinephrine stimulus (GO:0071872) | 2.26460591 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.65416816 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.54921614 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52121065 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.74701815 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.45607029 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.41669711 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 5.12422609 |
8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.97761843 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.08826339 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.93952541 |
11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.62379288 |
12 | GATA1_19941826_ChIP-Seq_K562_Human | 3.37858929 |
13 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.24051510 |
14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.07408911 |
15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.97387825 |
16 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.71281179 |
17 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.70744174 |
18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.57323821 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45418635 |
20 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.43567173 |
21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38511033 |
22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.27090723 |
23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09440661 |
24 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.09050670 |
25 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.99165799 |
26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83451302 |
27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78692587 |
28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78514105 |
29 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.77174226 |
30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76987380 |
31 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70217538 |
32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69666473 |
33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69072456 |
34 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67973404 |
35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62944601 |
36 | MYC_22102868_ChIP-Seq_BL_Human | 1.61967877 |
37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58159050 |
38 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56890283 |
39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56867723 |
40 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55870741 |
41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48068690 |
42 | MYB_26560356_Chip-Seq_TH1_Human | 1.46812524 |
43 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.45494040 |
44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.45010236 |
45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.43200037 |
46 | MYB_26560356_Chip-Seq_TH2_Human | 1.42984461 |
47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40769320 |
48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.40158127 |
49 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.39424962 |
50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.37417961 |
51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35322198 |
52 | MAF_26560356_Chip-Seq_TH1_Human | 1.34176634 |
53 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32796444 |
54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32282056 |
55 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28784955 |
56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28167754 |
57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27815318 |
58 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.27463800 |
59 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.26084075 |
60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25590418 |
61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25147947 |
62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24961579 |
63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24128896 |
64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23248028 |
65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23121164 |
66 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23029261 |
67 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21349168 |
68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20965463 |
69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20920744 |
70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20487367 |
71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19666346 |
72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19390818 |
73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18432878 |
74 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16866421 |
75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16608407 |
76 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13910207 |
77 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13796957 |
78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13403680 |
79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12457649 |
80 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.12344358 |
81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11742511 |
82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10886420 |
83 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10493687 |
84 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08725788 |
85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08172417 |
86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07016539 |
87 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.06541099 |
88 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.04784457 |
89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03263325 |
90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03232924 |
91 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.03189350 |
92 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.02745639 |
93 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.02668856 |
94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01245952 |
95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00937902 |
96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99005382 |
97 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.98639889 |
98 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98615846 |
99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98282468 |
100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98100756 |
101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96582931 |
102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96518037 |
103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96368392 |
104 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94882792 |
105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92292369 |
106 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92149254 |
107 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.91389025 |
108 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89734677 |
109 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.89148901 |
110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89095818 |
111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88897577 |
112 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85791211 |
113 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.85764296 |
114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85685428 |
115 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.85392594 |
116 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84722597 |
117 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83783065 |
118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83359840 |
119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83096789 |
120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78917157 |
121 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78836018 |
122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78597431 |
123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78003109 |
124 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.77546585 |
125 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76937324 |
126 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.76439223 |
127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76125904 |
128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75811547 |
129 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75587471 |
130 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.75021963 |
131 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.74250064 |
132 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73689282 |
133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73679205 |
134 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72985315 |
135 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.72427202 |
136 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.71904458 |
137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70981843 |
138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70967522 |
139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.69123205 |
140 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68708243 |
141 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.67748678 |
142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65028461 |
143 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.63523853 |
144 | ATF3_27146783_Chip-Seq_COLON_Human | 0.63362787 |
145 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.61740787 |
146 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.61358285 |
147 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.61323969 |
148 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.61142242 |
149 | P68_20966046_ChIP-Seq_HELA_Human | 0.61094579 |
150 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60245004 |
151 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60114775 |
152 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59068590 |
153 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.59043458 |
154 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58740908 |
155 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58716815 |
156 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.58707316 |
157 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.58642805 |
158 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.57297939 |
159 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.57297939 |
160 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57245021 |
161 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.57011430 |
162 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.56803406 |
163 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56608697 |
164 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.56476782 |
165 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.54653324 |
166 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.53602403 |
167 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.53575999 |
168 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53357024 |
169 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.53058196 |
170 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.52845684 |
171 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52268634 |
172 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51590357 |
173 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.49717957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.66257925 |
2 | * MP0003656_abnormal_erythrocyte_physiolo | 6.15542525 |
3 | MP0005360_urolithiasis | 5.97553882 |
4 | MP0004147_increased_porphyrin_level | 5.69674819 |
5 | MP0005085_abnormal_gallbladder_physiolo | 4.98825665 |
6 | MP0005365_abnormal_bile_salt | 4.44088696 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.97877345 |
8 | MP0005083_abnormal_biliary_tract | 3.93957542 |
9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.80505656 |
10 | MP0003252_abnormal_bile_duct | 3.00394234 |
11 | MP0003195_calcinosis | 2.84057990 |
12 | MP0010329_abnormal_lipoprotein_level | 2.80225323 |
13 | MP0009840_abnormal_foam_cell | 2.62357270 |
14 | MP0008057_abnormal_DNA_replication | 2.46450088 |
15 | MP0000015_abnormal_ear_pigmentation | 2.39611618 |
16 | MP0005332_abnormal_amino_acid | 2.39197841 |
17 | MP0005075_abnormal_melanosome_morpholog | 2.19362212 |
18 | MP0003172_abnormal_lysosome_physiology | 2.13162313 |
19 | MP0001666_abnormal_nutrient_absorption | 2.04976184 |
20 | MP0003191_abnormal_cellular_cholesterol | 2.03776189 |
21 | MP0005636_abnormal_mineral_homeostasis | 1.96968927 |
22 | * MP0000609_abnormal_liver_physiology | 1.95065792 |
23 | MP0006036_abnormal_mitochondrial_physio | 1.93838564 |
24 | MP0000569_abnormal_digit_pigmentation | 1.92786976 |
25 | MP0002396_abnormal_hematopoietic_system | 1.91164733 |
26 | MP0002118_abnormal_lipid_homeostasis | 1.88901768 |
27 | MP0003186_abnormal_redox_activity | 1.85598283 |
28 | MP0004808_abnormal_hematopoietic_stem | 1.82011774 |
29 | MP0002166_altered_tumor_susceptibility | 1.72912037 |
30 | MP0003111_abnormal_nucleus_morphology | 1.71717355 |
31 | MP0002837_dystrophic_cardiac_calcinosis | 1.68505749 |
32 | MP0003303_peritoneal_inflammation | 1.66991432 |
33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64362105 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.63095498 |
35 | * MP0005319_abnormal_enzyme/_coenzyme | 1.60296125 |
36 | MP0000372_irregular_coat_pigmentation | 1.59340574 |
37 | MP0008995_early_reproductive_senescence | 1.58932482 |
38 | MP0004381_abnormal_hair_follicle | 1.53182138 |
39 | MP0004130_abnormal_muscle_cell | 1.53021684 |
40 | MP0005174_abnormal_tail_pigmentation | 1.49040509 |
41 | MP0004019_abnormal_vitamin_homeostasis | 1.47283925 |
42 | MP0009643_abnormal_urine_homeostasis | 1.46840477 |
43 | MP0002877_abnormal_melanocyte_morpholog | 1.45388149 |
44 | MP0000749_muscle_degeneration | 1.40058703 |
45 | MP0001764_abnormal_homeostasis | 1.39986377 |
46 | * MP0002398_abnormal_bone_marrow | 1.36466230 |
47 | MP0002009_preneoplasia | 1.35506530 |
48 | MP0002095_abnormal_skin_pigmentation | 1.33392611 |
49 | MP0003763_abnormal_thymus_physiology | 1.30062394 |
50 | MP0003705_abnormal_hypodermis_morpholog | 1.29503361 |
51 | MP0009278_abnormal_bone_marrow | 1.27916324 |
52 | MP0003077_abnormal_cell_cycle | 1.26295265 |
53 | MP0010307_abnormal_tumor_latency | 1.26196422 |
54 | * MP0000689_abnormal_spleen_morphology | 1.25456029 |
55 | MP0010094_abnormal_chromosome_stability | 1.25158065 |
56 | * MP0002722_abnormal_immune_system | 1.25009398 |
57 | MP0003868_abnormal_feces_composition | 1.23861154 |
58 | MP0005171_absent_coat_pigmentation | 1.22018778 |
59 | MP0000371_diluted_coat_color | 1.17935199 |
60 | * MP0000598_abnormal_liver_morphology | 1.10898973 |
61 | MP0008775_abnormal_heart_ventricle | 1.09481283 |
62 | MP0000703_abnormal_thymus_morphology | 1.09079667 |
63 | MP0004043_abnormal_pH_regulation | 1.06905869 |
64 | MP0004957_abnormal_blastocyst_morpholog | 1.06119736 |
65 | MP0003786_premature_aging | 1.05204212 |
66 | MP0009764_decreased_sensitivity_to | 1.03338338 |
67 | MP0000685_abnormal_immune_system | 1.02678727 |
68 | MP0005666_abnormal_adipose_tissue | 1.01797737 |
69 | MP0002971_abnormal_brown_adipose | 1.01077960 |
70 | MP0003646_muscle_fatigue | 0.99255476 |
71 | MP0009763_increased_sensitivity_to | 0.97575178 |
72 | MP0005451_abnormal_body_composition | 0.97310854 |
73 | MP0005187_abnormal_penis_morphology | 0.96145644 |
74 | MP0005670_abnormal_white_adipose | 0.96093072 |
75 | * MP0002429_abnormal_blood_cell | 0.95243188 |
76 | MP0008058_abnormal_DNA_repair | 0.94822232 |
77 | MP0005621_abnormal_cell_physiology | 0.91708034 |
78 | MP0002006_tumorigenesis | 0.91042848 |
79 | MP0003011_delayed_dark_adaptation | 0.90300509 |
80 | MP0000747_muscle_weakness | 0.89162011 |
81 | MP0002078_abnormal_glucose_homeostasis | 0.88718465 |
82 | MP0005310_abnormal_salivary_gland | 0.88342223 |
83 | MP0004233_abnormal_muscle_weight | 0.88280885 |
84 | MP0009697_abnormal_copulation | 0.87866508 |
85 | MP0002019_abnormal_tumor_incidence | 0.87320825 |
86 | MP0004185_abnormal_adipocyte_glucose | 0.87137456 |
87 | MP0000604_amyloidosis | 0.86015807 |
88 | MP0006035_abnormal_mitochondrial_morpho | 0.85852599 |
89 | MP0001730_embryonic_growth_arrest | 0.84654915 |
90 | MP0005384_cellular_phenotype | 0.84267246 |
91 | MP0005535_abnormal_body_temperature | 0.83399333 |
92 | MP0000313_abnormal_cell_death | 0.82800047 |
93 | MP0005330_cardiomyopathy | 0.82511396 |
94 | MP0002269_muscular_atrophy | 0.82348421 |
95 | MP0001756_abnormal_urination | 0.81806345 |
96 | MP0005334_abnormal_fat_pad | 0.80033514 |
97 | MP0009765_abnormal_xenobiotic_induced | 0.79356853 |
98 | MP0003828_pulmonary_edema | 0.78325912 |
99 | MP0005076_abnormal_cell_differentiation | 0.78105214 |
100 | * MP0009642_abnormal_blood_homeostasis | 0.77293316 |
101 | MP0004215_abnormal_myocardial_fiber | 0.76219184 |
102 | MP0005376_homeostasis/metabolism_phenot | 0.76085195 |
103 | MP0002405_respiratory_system_inflammati | 0.75046678 |
104 | MP0001661_extended_life_span | 0.74918125 |
105 | MP0005464_abnormal_platelet_physiology | 0.74459025 |
106 | MP0005266_abnormal_metabolism | 0.74025134 |
107 | MP0004145_abnormal_muscle_electrophysio | 0.72630441 |
108 | MP0010368_abnormal_lymphatic_system | 0.72362033 |
109 | MP0004036_abnormal_muscle_relaxation | 0.71452069 |
110 | MP0004484_altered_response_of | 0.70819113 |
111 | MP0001835_abnormal_antigen_presentation | 0.70437337 |
112 | MP0003984_embryonic_growth_retardation | 0.70145642 |
113 | MP0001545_abnormal_hematopoietic_system | 0.69786829 |
114 | MP0005397_hematopoietic_system_phenotyp | 0.69786829 |
115 | MP0002088_abnormal_embryonic_growth/wei | 0.69278873 |
116 | MP0001915_intracranial_hemorrhage | 0.69014263 |
117 | MP0000716_abnormal_immune_system | 0.68673198 |
118 | MP0003329_amyloid_beta_deposits | 0.68376240 |
119 | MP0002086_abnormal_extraembryonic_tissu | 0.68279604 |
120 | MP0009333_abnormal_splenocyte_physiolog | 0.67779253 |
121 | * MP0008469_abnormal_protein_level | 0.67198129 |
122 | MP0005647_abnormal_sex_gland | 0.66156061 |
123 | MP0000858_altered_metastatic_potential | 0.65650300 |
124 | MP0005025_abnormal_response_to | 0.65483950 |
125 | MP0004883_abnormal_blood_vessel | 0.65131139 |
126 | MP0000350_abnormal_cell_proliferation | 0.64946350 |
127 | MP0008872_abnormal_physiological_respon | 0.64519887 |
128 | MP0000358_abnormal_cell_content/ | 0.64287518 |
129 | MP0002419_abnormal_innate_immunity | 0.64062701 |
130 | * MP0002080_prenatal_lethality | 0.64058190 |
131 | MP0005380_embryogenesis_phenotype | 0.62576954 |
132 | MP0001672_abnormal_embryogenesis/_devel | 0.62576954 |
133 | MP0003300_gastrointestinal_ulcer | 0.61679576 |
134 | MP0008877_abnormal_DNA_methylation | 0.61540768 |
135 | MP0005375_adipose_tissue_phenotype | 0.61375922 |
136 | MP0004087_abnormal_muscle_fiber | 0.61365434 |
137 | MP0001697_abnormal_embryo_size | 0.61158867 |
138 | MP0002420_abnormal_adaptive_immunity | 0.61099571 |
139 | MP0006054_spinal_hemorrhage | 0.58821721 |
140 | MP0005620_abnormal_muscle_contractility | 0.58505269 |
141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58454113 |
142 | MP0009931_abnormal_skin_appearance | 0.57565261 |
143 | MP0008438_abnormal_cutaneous_collagen | 0.56302658 |
144 | MP0001765_abnormal_ion_homeostasis | 0.55561915 |
145 | MP0002972_abnormal_cardiac_muscle | 0.55307849 |
146 | MP0002970_abnormal_white_adipose | 0.54926155 |
147 | MP0002136_abnormal_kidney_physiology | 0.54722859 |
148 | MP0000230_abnormal_systemic_arterial | 0.53934522 |
149 | MP0005448_abnormal_energy_balance | 0.53575038 |
150 | MP0001544_abnormal_cardiovascular_syste | 0.51618745 |
151 | MP0005385_cardiovascular_system_phenoty | 0.51618745 |
152 | MP0008260_abnormal_autophagy | 0.51301717 |
153 | MP0002132_abnormal_respiratory_system | 0.49737317 |
154 | MP0003690_abnormal_glial_cell | 0.49485524 |
155 | MP0004084_abnormal_cardiac_muscle | 0.49349907 |
156 | MP0000759_abnormal_skeletal_muscle | 0.48687862 |
157 | MP0005220_abnormal_exocrine_pancreas | 0.48492460 |
158 | MP0005058_abnormal_lysosome_morphology | 0.47927036 |
159 | MP0002332_abnormal_exercise_endurance | 0.47762675 |
160 | MP0003075_altered_response_to | 0.45665464 |
161 | MP0000751_myopathy | 0.44750980 |
162 | MP0009053_abnormal_anal_canal | 0.43808017 |
163 | MP0001243_abnormal_dermal_layer | 0.42787334 |
164 | MP0005408_hypopigmentation | 0.39913116 |
165 | MP0010630_abnormal_cardiac_muscle | 0.39801175 |
166 | MP0005084_abnormal_gallbladder_morpholo | 0.38483302 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 7.82848048 |
2 | Poikilocytosis (HP:0004447) | 7.73042897 |
3 | Acanthocytosis (HP:0001927) | 6.23469905 |
4 | Hypochromic microcytic anemia (HP:0004840) | 6.21024003 |
5 | Reticulocytosis (HP:0001923) | 5.39818973 |
6 | Hyperbilirubinemia (HP:0002904) | 5.25633315 |
7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.16100873 |
8 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 5.07820022 |
9 | Deep venous thrombosis (HP:0002625) | 5.02630249 |
10 | Intrahepatic cholestasis (HP:0001406) | 4.94698233 |
11 | * Cholelithiasis (HP:0001081) | 4.91181712 |
12 | Abnormal hemoglobin (HP:0011902) | 4.81208651 |
13 | Xanthomatosis (HP:0000991) | 4.74635900 |
14 | * Abnormal gallbladder morphology (HP:0012437) | 4.65729876 |
15 | Abnormal gallbladder physiology (HP:0012438) | 4.29948843 |
16 | Cholecystitis (HP:0001082) | 4.29948843 |
17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.25708701 |
18 | Prolonged partial thromboplastin time (HP:0003645) | 4.14957172 |
19 | Hypobetalipoproteinemia (HP:0003563) | 4.13809643 |
20 | Hyperlipoproteinemia (HP:0010980) | 3.94134549 |
21 | Hyperammonemia (HP:0001987) | 3.74180689 |
22 | Paralysis (HP:0003470) | 3.71682209 |
23 | Ketosis (HP:0001946) | 3.68063780 |
24 | Hypoglycemic coma (HP:0001325) | 3.67840511 |
25 | Diaphragmatic weakness (HP:0009113) | 3.64051558 |
26 | Hypolipoproteinemia (HP:0010981) | 3.55965768 |
27 | Complement deficiency (HP:0004431) | 3.55750471 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 3.46775623 |
29 | Hepatocellular carcinoma (HP:0001402) | 3.45231520 |
30 | * Abnormality of the gallbladder (HP:0005264) | 3.37168155 |
31 | Orthostatic hypotension (HP:0001278) | 3.32380753 |
32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.30324962 |
33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28657277 |
34 | Prolonged bleeding time (HP:0003010) | 3.16745791 |
35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.15258612 |
36 | Abnormality of glycine metabolism (HP:0010895) | 3.15258612 |
37 | Abnormality of reticulocytes (HP:0004312) | 3.13305421 |
38 | Hyperglycinemia (HP:0002154) | 3.13038201 |
39 | Abnormality of the common coagulation pathway (HP:0010990) | 3.12694795 |
40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.09000943 |
41 | Hyperglycinuria (HP:0003108) | 3.07668826 |
42 | Visual hallucinations (HP:0002367) | 3.07592892 |
43 | Joint hemorrhage (HP:0005261) | 3.04856242 |
44 | Toxemia of pregnancy (HP:0100603) | 3.01405921 |
45 | Metabolic acidosis (HP:0001942) | 3.01331003 |
46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.98950423 |
47 | Slow saccadic eye movements (HP:0000514) | 2.97622744 |
48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.94352909 |
49 | Ketoacidosis (HP:0001993) | 2.92440760 |
50 | Epidermoid cyst (HP:0200040) | 2.91927005 |
51 | Polycythemia (HP:0001901) | 2.90342721 |
52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87528761 |
53 | Ileus (HP:0002595) | 2.86470488 |
54 | Abnormality of methionine metabolism (HP:0010901) | 2.81578683 |
55 | Nausea (HP:0002018) | 2.78404321 |
56 | Hypochromic anemia (HP:0001931) | 2.76361487 |
57 | Abnormality of iron homeostasis (HP:0011031) | 2.70616148 |
58 | Fat malabsorption (HP:0002630) | 2.67642864 |
59 | Dicarboxylic aciduria (HP:0003215) | 2.67282591 |
60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.67282591 |
61 | Increased serum ferritin (HP:0003281) | 2.67070977 |
62 | Papillary thyroid carcinoma (HP:0002895) | 2.65802953 |
63 | Abnormality of the fingertips (HP:0001211) | 2.65287393 |
64 | Abnormality of the intrinsic pathway (HP:0010989) | 2.65245865 |
65 | Abnormality of complement system (HP:0005339) | 2.63926641 |
66 | Gastrointestinal infarctions (HP:0005244) | 2.62909807 |
67 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.57614785 |
68 | Recurrent bacterial skin infections (HP:0005406) | 2.44160833 |
69 | Abnormality of purine metabolism (HP:0004352) | 2.42055346 |
70 | Hypercholesterolemia (HP:0003124) | 2.41971244 |
71 | Gout (HP:0001997) | 2.41665917 |
72 | Myoglobinuria (HP:0002913) | 2.37808320 |
73 | Osteomalacia (HP:0002749) | 2.36294235 |
74 | Cerebral edema (HP:0002181) | 2.36264435 |
75 | Generalized aminoaciduria (HP:0002909) | 2.36189791 |
76 | Vomiting (HP:0002013) | 2.33839338 |
77 | Abnormality of nucleobase metabolism (HP:0010932) | 2.33691234 |
78 | Epistaxis (HP:0000421) | 2.32770874 |
79 | Abnormality of serum amino acid levels (HP:0003112) | 2.32159967 |
80 | Recurrent abscess formation (HP:0002722) | 2.29549078 |
81 | Global brain atrophy (HP:0002283) | 2.28904712 |
82 | Lethargy (HP:0001254) | 2.28445928 |
83 | Cerebral palsy (HP:0100021) | 2.24476865 |
84 | Gingival bleeding (HP:0000225) | 2.24211033 |
85 | Thyroid carcinoma (HP:0002890) | 2.22512298 |
86 | T lymphocytopenia (HP:0005403) | 2.22108577 |
87 | Delayed CNS myelination (HP:0002188) | 2.20277162 |
88 | Increased mean platelet volume (HP:0011877) | 2.18104092 |
89 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.16963010 |
90 | Rickets (HP:0002748) | 2.12943112 |
91 | Myocardial infarction (HP:0001658) | 2.12700925 |
92 | Albinism (HP:0001022) | 2.12640593 |
93 | Fatigue (HP:0012378) | 2.09872038 |
94 | Confusion (HP:0001289) | 2.09458554 |
95 | Abnormal platelet volume (HP:0011876) | 2.07199945 |
96 | Spontaneous hematomas (HP:0007420) | 2.07197943 |
97 | Abnormality of T cell number (HP:0011839) | 2.05867629 |
98 | Autoimmune hemolytic anemia (HP:0001890) | 2.05247660 |
99 | Skin nodule (HP:0200036) | 2.04700906 |
100 | Recurrent viral infections (HP:0004429) | 2.02795428 |
101 | Conjunctival telangiectasia (HP:0000524) | 2.01801504 |
102 | Insomnia (HP:0100785) | 2.01541188 |
103 | Brushfield spots (HP:0001088) | 1.99856005 |
104 | Steatorrhea (HP:0002570) | 1.99680342 |
105 | Long clavicles (HP:0000890) | 1.99437864 |
106 | Nonimmune hydrops fetalis (HP:0001790) | 1.96524445 |
107 | Acute myeloid leukemia (HP:0004808) | 1.96344794 |
108 | Hypoglycemic seizures (HP:0002173) | 1.95094076 |
109 | Postural instability (HP:0002172) | 1.93786167 |
110 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93405271 |
111 | Autoamputation (HP:0001218) | 1.93370813 |
112 | Rhabdomyolysis (HP:0003201) | 1.93289518 |
113 | Osteolytic defects of the hand bones (HP:0009699) | 1.92368812 |
114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92368812 |
115 | Conjugated hyperbilirubinemia (HP:0002908) | 1.92184950 |
116 | Osteomyelitis (HP:0002754) | 1.90066006 |
117 | Hepatic necrosis (HP:0002605) | 1.89255486 |
118 | Hemorrhage of the eye (HP:0011885) | 1.87510101 |
119 | Spontaneous abortion (HP:0005268) | 1.86800014 |
120 | Viral hepatitis (HP:0006562) | 1.85498236 |
121 | Dysautonomia (HP:0002459) | 1.84817170 |
122 | * Microcytic anemia (HP:0001935) | 1.84202625 |
123 | Sensorimotor neuropathy (HP:0007141) | 1.84146265 |
124 | * Cutaneous photosensitivity (HP:0000992) | 1.83612242 |
125 | Late onset (HP:0003584) | 1.81522229 |
126 | Testicular neoplasm (HP:0010788) | 1.80608712 |
127 | Ocular albinism (HP:0001107) | 1.80129879 |
128 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.78919441 |
129 | Irritability (HP:0000737) | 1.78138275 |
130 | Vascular calcification (HP:0004934) | 1.77505952 |
131 | Subacute progressive viral hepatitis (HP:0006572) | 1.77288113 |
132 | Increased purine levels (HP:0004368) | 1.76175354 |
133 | Hyperuricemia (HP:0002149) | 1.76175354 |
134 | Lower limb hyperreflexia (HP:0002395) | 1.75061060 |
135 | Exercise-induced muscle cramps (HP:0003710) | 1.74780290 |
136 | Resting tremor (HP:0002322) | 1.74219242 |
137 | Proximal tubulopathy (HP:0000114) | 1.73201694 |
138 | Cerebral inclusion bodies (HP:0100314) | 1.72535711 |
139 | Anhidrosis (HP:0000970) | 1.72261572 |
140 | Abnormality of the Achilles tendon (HP:0005109) | 1.72202575 |
141 | Impaired platelet aggregation (HP:0003540) | 1.72091091 |
142 | Abnormal platelet function (HP:0011869) | 1.72091091 |
143 | Abnormal cartilage morphology (HP:0002763) | 1.71808850 |
144 | Petechiae (HP:0000967) | 1.70946351 |
145 | Thrombophlebitis (HP:0004418) | 1.70868367 |
146 | Abnormality of urine glucose concentration (HP:0011016) | 1.70446441 |
147 | Glycosuria (HP:0003076) | 1.70446441 |
148 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.68584810 |
149 | Hypertensive crisis (HP:0100735) | 1.67258587 |
150 | Recurrent fungal infections (HP:0002841) | 1.65977979 |
151 | Muscle fibrillation (HP:0010546) | 1.65934394 |
152 | Pustule (HP:0200039) | 1.65444709 |
153 | Autoimmune thrombocytopenia (HP:0001973) | 1.62074073 |
154 | Difficulty running (HP:0009046) | 1.59887953 |
155 | Abnormality of saccadic eye movements (HP:0000570) | 1.59235693 |
156 | Anorexia (HP:0002039) | 1.57875244 |
157 | Abnormality of T cells (HP:0002843) | 1.55809403 |
158 | Arterial thrombosis (HP:0004420) | 1.55653845 |
159 | Pallor (HP:0000980) | 1.55560434 |
160 | Eczematoid dermatitis (HP:0000976) | 1.55501106 |
161 | Recurrent skin infections (HP:0001581) | 1.53970685 |
162 | Acute hepatic failure (HP:0006554) | 1.53848667 |
163 | Germ cell neoplasia (HP:0100728) | 1.53696768 |
164 | Cutaneous melanoma (HP:0012056) | 1.53101556 |
165 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.50260989 |
166 | Hyponatremia (HP:0002902) | 1.50252262 |
167 | Gingivitis (HP:0000230) | 1.49446321 |
168 | Gonadal dysgenesis (HP:0000133) | 1.46732344 |
169 | Splenomegaly (HP:0001744) | 1.45923705 |
170 | Increased connective tissue (HP:0009025) | 1.45382576 |
171 | Recurrent cutaneous fungal infections (HP:0011370) | 1.44837261 |
172 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.44837261 |
173 | Inflammation of the large intestine (HP:0002037) | 1.43607334 |
174 | Delusions (HP:0000746) | 1.42640610 |
175 | Hypoparathyroidism (HP:0000829) | 1.42573193 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.58801479 |
2 | EIF2AK1 | 5.52357399 |
3 | PRPF4B | 3.25347949 |
4 | TRIB3 | 3.21921497 |
5 | TLK1 | 2.96549272 |
6 | STK4 | 2.51632463 |
7 | ERN1 | 2.49246350 |
8 | PKN2 | 2.43489597 |
9 | SIK1 | 2.35208286 |
10 | TAOK3 | 2.26581633 |
11 | MAPK11 | 2.14832843 |
12 | RIPK4 | 2.09376448 |
13 | WNK1 | 2.05014285 |
14 | PLK2 | 1.98840497 |
15 | FGR | 1.92931880 |
16 | TTN | 1.69593178 |
17 | CLK1 | 1.68013281 |
18 | FGFR4 | 1.66960820 |
19 | SMG1 | 1.59471780 |
20 | PLK3 | 1.58466143 |
21 | MAP2K3 | 1.57479164 |
22 | FLT3 | 1.57299617 |
23 | PIK3CG | 1.55428985 |
24 | ZAK | 1.53719849 |
25 | ABL2 | 1.53254748 |
26 | NME2 | 1.52066710 |
27 | MARK3 | 1.51526137 |
28 | MAP3K11 | 1.50614087 |
29 | OBSCN | 1.49543891 |
30 | NEK1 | 1.44235991 |
31 | INSRR | 1.42343422 |
32 | NEK9 | 1.41488063 |
33 | JAK2 | 1.32625402 |
34 | WNK4 | 1.29954652 |
35 | PINK1 | 1.27363957 |
36 | PRKAA1 | 1.26722346 |
37 | PRKAA2 | 1.26539048 |
38 | BRSK1 | 1.24970738 |
39 | RAF1 | 1.24019077 |
40 | KSR1 | 1.15828253 |
41 | IKBKE | 1.15647826 |
42 | NUAK1 | 1.15468779 |
43 | MAPKAPK3 | 1.09537428 |
44 | TAF1 | 1.09230298 |
45 | TRPM7 | 1.05794999 |
46 | PDK3 | 1.04254880 |
47 | PDK4 | 1.04254880 |
48 | ERBB2 | 1.03384962 |
49 | BLK | 1.03276668 |
50 | TGFBR2 | 1.03065017 |
51 | DYRK1B | 1.02844237 |
52 | TEC | 1.00485629 |
53 | MAP3K2 | 1.00370414 |
54 | MAP3K8 | 0.98933521 |
55 | STK10 | 0.98635652 |
56 | MAP2K4 | 0.98201471 |
57 | EIF2AK3 | 0.95365098 |
58 | KDR | 0.95289531 |
59 | GRK6 | 0.94611508 |
60 | MET | 0.92157207 |
61 | MAP2K1 | 0.90988350 |
62 | DAPK2 | 0.89935214 |
63 | MAP3K7 | 0.89654034 |
64 | KSR2 | 0.89134890 |
65 | MAPK12 | 0.88868911 |
66 | CDK6 | 0.88045294 |
67 | CAMK1D | 0.86650789 |
68 | TYK2 | 0.84488058 |
69 | PBK | 0.84403453 |
70 | MST1R | 0.83853773 |
71 | CAMK1G | 0.82184918 |
72 | JAK3 | 0.77787607 |
73 | PHKG1 | 0.77325926 |
74 | PHKG2 | 0.77325926 |
75 | BMPR2 | 0.77054494 |
76 | PTK2B | 0.76661795 |
77 | PRKACG | 0.76432136 |
78 | PIM1 | 0.75893588 |
79 | RPS6KA5 | 0.75892558 |
80 | SCYL2 | 0.74808391 |
81 | MAPKAPK5 | 0.74523832 |
82 | SGK223 | 0.73063351 |
83 | SGK494 | 0.73063351 |
84 | HIPK2 | 0.71822431 |
85 | TAOK1 | 0.71463797 |
86 | PKN1 | 0.70802713 |
87 | DYRK3 | 0.70437171 |
88 | PIK3CA | 0.69359124 |
89 | CDK12 | 0.68801890 |
90 | MST4 | 0.68526616 |
91 | SGK3 | 0.68283980 |
92 | MAP3K3 | 0.67773459 |
93 | BMX | 0.67519772 |
94 | EPHB1 | 0.67154572 |
95 | PDPK1 | 0.66497009 |
96 | BTK | 0.65247657 |
97 | MAP3K10 | 0.65135757 |
98 | ERBB4 | 0.64371369 |
99 | PTK6 | 0.63845390 |
100 | TBK1 | 0.60512886 |
101 | BRD4 | 0.58474615 |
102 | TIE1 | 0.58414904 |
103 | DYRK1A | 0.55615005 |
104 | LRRK2 | 0.52740749 |
105 | CDK4 | 0.51835839 |
106 | LYN | 0.51655757 |
107 | BRSK2 | 0.50573407 |
108 | TAOK2 | 0.50513318 |
109 | AKT3 | 0.50458889 |
110 | ICK | 0.49435918 |
111 | HCK | 0.49065730 |
112 | RET | 0.48971445 |
113 | SGK1 | 0.48757690 |
114 | FGFR3 | 0.45545930 |
115 | PDK1 | 0.45150837 |
116 | AURKA | 0.44942282 |
117 | TNK2 | 0.44036759 |
118 | VRK1 | 0.43925362 |
119 | IRAK4 | 0.43705644 |
120 | MAP3K6 | 0.43662497 |
121 | EEF2K | 0.43292468 |
122 | YES1 | 0.42035831 |
123 | GRK7 | 0.40862414 |
124 | DAPK3 | 0.40188399 |
125 | STK3 | 0.39992552 |
126 | ACVR1B | 0.38299511 |
127 | CHEK1 | 0.37007471 |
128 | MAP3K5 | 0.36803985 |
129 | MYLK | 0.36579794 |
130 | MELK | 0.36321829 |
131 | ZAP70 | 0.36044914 |
132 | PLK1 | 0.36036081 |
133 | STK11 | 0.35625985 |
134 | RPS6KB2 | 0.35126704 |
135 | IRAK1 | 0.34373140 |
136 | CSK | 0.33645501 |
137 | AKT2 | 0.33590859 |
138 | ATM | 0.32538826 |
139 | SGK2 | 0.32391238 |
140 | MAP3K1 | 0.31673865 |
141 | AURKB | 0.31493469 |
142 | FES | 0.31027913 |
143 | GRK5 | 0.30998661 |
144 | BUB1 | 0.29899716 |
145 | MTOR | 0.29839295 |
146 | SYK | 0.29302984 |
147 | CDK9 | 0.29088626 |
148 | PRKACB | 0.28231208 |
149 | IRAK3 | 0.28160844 |
150 | AKT1 | 0.27628793 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.56815954 |
2 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.24163590 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.23443890 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07009267 |
5 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 3.01444324 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78839028 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78185384 |
8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.76874512 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71241395 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.59368383 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51678636 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.41279059 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.39880611 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37219250 |
15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.34941654 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17157751 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12084766 |
18 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.11133505 |
19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.03441976 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.00681806 |
21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99545448 |
22 | Peroxisome_Homo sapiens_hsa04146 | 1.94497285 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85602745 |
24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85319489 |
25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.79816303 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.79574388 |
27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72078102 |
28 | Cell cycle_Homo sapiens_hsa04110 | 1.70954733 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68025478 |
30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65886403 |
31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.64472263 |
32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61748957 |
33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60911476 |
34 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.55248250 |
35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54848033 |
36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.54759693 |
37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.54352893 |
38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53993362 |
39 | ABC transporters_Homo sapiens_hsa02010 | 1.53289090 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51145123 |
41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50471033 |
42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49798152 |
43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47458599 |
44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47042830 |
45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44796666 |
46 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.43097317 |
47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42960279 |
48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.41548748 |
49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38238363 |
50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.37066573 |
51 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.36552330 |
52 | Bile secretion_Homo sapiens_hsa04976 | 1.35975411 |
53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35099197 |
54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.34723119 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 1.32679399 |
56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31436649 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30134224 |
58 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28722439 |
59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28569952 |
60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28202889 |
61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27930815 |
62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27301499 |
63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27173834 |
64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26314344 |
65 | DNA replication_Homo sapiens_hsa03030 | 1.22934741 |
66 | Prostate cancer_Homo sapiens_hsa05215 | 1.22016259 |
67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21665564 |
68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.21309997 |
69 | Platelet activation_Homo sapiens_hsa04611 | 1.16798959 |
70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.16402509 |
71 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15826039 |
72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15522661 |
73 | Measles_Homo sapiens_hsa05162 | 1.14174158 |
74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14111633 |
75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13519613 |
76 | Apoptosis_Homo sapiens_hsa04210 | 1.13030855 |
77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12494000 |
78 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10008987 |
79 | Glioma_Homo sapiens_hsa05214 | 1.09929487 |
80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02667411 |
81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00773972 |
82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00539873 |
83 | Hepatitis C_Homo sapiens_hsa05160 | 0.99013729 |
84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98490189 |
85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95734016 |
86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93430387 |
87 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92583295 |
88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89689261 |
89 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.89664472 |
90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88185056 |
91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87258517 |
92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.87242578 |
93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87052133 |
94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86266002 |
95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83371658 |
96 | Base excision repair_Homo sapiens_hsa03410 | 0.81787035 |
97 | Mismatch repair_Homo sapiens_hsa03430 | 0.81080619 |
98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80935366 |
99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79353578 |
100 | Legionellosis_Homo sapiens_hsa05134 | 0.78797067 |
101 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77391975 |
102 | Lysine degradation_Homo sapiens_hsa00310 | 0.75833043 |
103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75755013 |
104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73896400 |
105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73563017 |
106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72712659 |
107 | Influenza A_Homo sapiens_hsa05164 | 0.70956452 |
108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70176926 |
109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69482689 |
110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68680076 |
111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68524972 |
112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68416117 |
113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68142942 |
114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65836459 |
115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65395310 |
116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64753866 |
117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63371451 |
118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62791422 |
119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60321266 |
120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60212556 |
121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59857173 |
122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58730027 |
123 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56617119 |
124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55872928 |
125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54120090 |
126 | Melanoma_Homo sapiens_hsa05218 | 0.53578748 |
127 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53518965 |
128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52788033 |
129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52651733 |
130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51784132 |
131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51521899 |
132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50878397 |
133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50787418 |
134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45228897 |
135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41966248 |
136 | Insulin resistance_Homo sapiens_hsa04931 | 0.38224419 |
137 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37494334 |
138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37316485 |
139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37029687 |
140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33979147 |
141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32753366 |
142 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31511665 |
143 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26596227 |
144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25790157 |
145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24862689 |
146 | Alcoholism_Homo sapiens_hsa05034 | 0.24419562 |
147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18140802 |
148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17442941 |
149 | Prion diseases_Homo sapiens_hsa05020 | 0.11139787 |
150 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10785229 |
151 | Bladder cancer_Homo sapiens_hsa05219 | 0.10349882 |
152 | Alzheimers disease_Homo sapiens_hsa05010 | 0.09759552 |
153 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.05392835 |
154 | Malaria_Homo sapiens_hsa05144 | 0.04665039 |
155 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.04624841 |
156 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.01870630 |
157 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.01188320 |
158 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.1272005 |
159 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0923754 |
160 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0836994 |
161 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0585126 |
162 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0456322 |
163 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0189592 |
164 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0118020 |